Fudan University

NCT07815834

Phase 3, Not yet recruiting, 2026, 198 people, 11 Sept 2026, clinicaltrials.gov

NCT07776340

Phase 2, Not yet recruiting, 2026, 104 people, 20 Aug 2026, clinicaltrials.gov

NCT07762885

Phase 3, Recruiting, 2026, 636 people, 13 Aug 2026, clinicaltrials.gov

NCT07711171

Phase 4, Recruiting, 2024, 60 people, 17 Jul 2026, clinicaltrials.gov

NCT07432178

Phase 3, Recruiting, 2026, 2,288 people, 25 Feb 2026, clinicaltrials.gov

NCT07423611

Phase 2, Not yet recruiting, 2026, 388 people, 20 Feb 2026, clinicaltrials.gov

NCT07407517

Phase 3, Not yet recruiting, 2026, 904 people, 12 Feb 2026, clinicaltrials.gov

NCT07362914

Phase 3, Recruiting, 2025, 182 people, 23 Jan 2026, clinicaltrials.gov

NCT07362836

Phase 3, Not yet recruiting, 2026, 224 people, 23 Jan 2026, clinicaltrials.gov

NCT07319429

Phase 2/3, Recruiting, 2026, 260 people, 6 Jan 2026, clinicaltrials.gov

NCT07154316

Phase 2, Recruiting, 2025, 138 people, 4 Sept 2025, clinicaltrials.gov

NCT07150949

Phase 2, Recruiting, 2025, 138 people, 2 Sept 2025, clinicaltrials.gov

NCT07117630

Phase 2, Recruiting, 2025, 60 people, 12 Aug 2025, clinicaltrials.gov

NCT07109401

Phase 2, Recruiting, 2025, 37 people, 7 Aug 2025, clinicaltrials.gov

NCT07019363

Phase 3, Recruiting, 2025, 1,903 people, 13 Jun 2025, clinicaltrials.gov

NCT07005557

Phase 3, Not yet recruiting, 2025, 1,244 people, 5 Jun 2025, clinicaltrials.gov

NCT06996093

Phase 3, Not yet recruiting, 2025, 2,508 people, 30 May 2025, clinicaltrials.gov

NCT06943235

Phase 2, Recruiting, 2025, 60 people, 24 Apr 2025, clinicaltrials.gov

NCT06914297

Phase 2, Recruiting, 2025, 10 people, 6 Apr 2025, clinicaltrials.gov

NCT06913777

Phase 3, Recruiting, 2025, 404 people, 6 Apr 2025, clinicaltrials.gov

β-Nicotinamide Mononucleotide Inhibits Cellular Senescence in Mouse C2C12 Skeletal Muscle Cells

FDUROP 254451, 22 Sept 2026, api.crossref.org

A wearable accelerometry landscape of human health and disease

25TQ010, 21TQ1400100, 22 Sept 2026, api.crossref.org